PolymarketVerificar disponibilidadeSem KYC2% de taxaDados de resolução verificadosBem calibradoProbabilidade implícita atual
December 50%-0.5pt
Qualidade do mercado
30 / 100
Baixa qualidadeVolume 24h
237,9 €
Liquidez
135 €
Baixa liquidezCompra / Venda
14.0% / 85.0%
Spread
71.0 pt
Spread amploComentários
0
Variação 7d
-2.0 pts
Dados do mercado
Atualizado há 6 minutos
23/06/26, 02:13 UTC1/01/27, 04:59 UTC
Tendências
0%
Mercados Relacionados
Perguntas relacionadas para dar contexto, não uma comparação de contratos equivalentes.
When will the FDA reclassify BPC-157 to Category 1?
KalshiWhat will Trump say during his announcement on healthcare?
KalshiHeidi Overton confirmed as FDA Commissioner by which date?
PolymarketWill the ACA premium tax credits be extended?
KalshiWill hemp-derived CBN sleep products still be federally legal as “hemp” on Nov 12, 2026?
Manifold MarketsWill Anthony Fauci be arrested before 2029?
Manifold MarketsRegras
This market will resolve to “Yes” if the Food and Drug Administration (FDA) announces that it has reclassified or will reclassify BPC-157 to Category 1 of the Bulk Drug Substances List by the listed date, 11:59 PM ET.
- Otherwise, this market will resolve to “No”.
- A qualifying announcement must be official and public.
- Any rumored or private statements of intention will not qualify.
- Any announcement that the drug has been reclassified to Category 1 will qualify.
- Any announcement within this market’s timeframe of future intention to reclassify to Category 1 will qualify regardless of whether the reclassification has happened by the listed date.